Arrow Mark Colorado Holdings LLC Albireo Pharma, Inc. Transaction History

Arrow Mark Colorado Holdings LLC

$7.03 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$18.01 - $23.78 $82,575 - $109,031	-4,585 Reduced 0.58%	786,664 $17 Million
Q3 2022 Nov 14, 2022	BUY	$16.32 - $26.37 $3.01 Million - $4.86 Million	184,286 Added 30.36%	791,249 $15.3 Million
Q2 2022 Aug 15, 2022	SELL	$18.54 - $37.29 $629,062 - $1.27 Million	-33,930 Reduced 5.29%	606,963 $12.1 Million
Q1 2022 May 16, 2022	BUY	$23.94 - $33.74 $108,855 - $153,415	4,547 Added 0.71%	640,893 $19.1 Million
Q4 2021 Feb 14, 2022	BUY	$21.19 - $31.29 $143,435 - $211,802	6,769 Added 1.08%	636,346 $14.8 Million
Q3 2021 Nov 15, 2021	SELL	$27.36 - $35.98 $1.43 Million - $1.89 Million	-52,424 Reduced 7.69%	629,577 $19.6 Million
Q2 2021 Aug 16, 2021	SELL	$28.9 - $36.87 $483,959 - $617,425	-16,746 Reduced 2.4%	682,001 $24 Million
Q1 2021 May 17, 2021	SELL	$32.03 - $42.85 $1.69 Million - $2.26 Million	-52,748 Reduced 7.02%	698,747 $24.6 Million
Q4 2020 Feb 16, 2021	SELL	$31.56 - $42.16 $1.49 Million - $1.98 Million	-47,069 Reduced 5.89%	751,495 $28.2 Million
Q3 2020 Nov 16, 2020	SELL	$23.19 - $41.61 $3.67 Million - $6.59 Million	-158,426 Reduced 16.55%	798,564 $26.6 Million
Q2 2020 Aug 14, 2020	SELL	$14.82 - $29.92 $227,961 - $460,229	-15,382 Reduced 1.58%	956,990 $25.4 Million
Q1 2020 May 15, 2020	BUY	$11.67 - $27.23 $1.23 Million - $2.87 Million	105,322 Added 12.15%	972,372 $15.9 Million
Q4 2019 Feb 14, 2020	BUY	$16.92 - $28.96 $4.12 Million - $7.06 Million	243,670 Added 39.09%	867,050 $22 Million
Q3 2019 Nov 14, 2019	BUY	$20.0 - $31.88 $1.35 Million - $2.16 Million	67,652 Added 12.17%	623,380 $12.5 Million
Q2 2019 Aug 14, 2019	SELL	$30.67 - $37.86 $3.21 Million - $3.96 Million	-104,714 Reduced 15.86%	555,728 $17.9 Million
Q1 2019 May 15, 2019	BUY	$22.22 - $32.21 $1.08 Million - $1.56 Million	48,450 Added 7.92%	660,442 $21.3 Million
Q4 2018 Feb 14, 2019	BUY	$20.9 - $32.57 $1.17 Million - $1.82 Million	55,925 Added 10.06%	611,992 $15 Million
Q3 2018 Nov 14, 2018	BUY	$29.29 - $36.87 $1.25 Million - $1.58 Million	42,818 Added 8.34%	556,067 $18.3 Million
Q2 2018 Aug 14, 2018	BUY	$28.9 - $37.31 $3.12 Million - $4.03 Million	107,897 Added 26.62%	513,249 $18.2 Million
Q1 2018 May 15, 2018	BUY	$26.78 - $39.35 $10.9 Million - $16 Million	405,352 New	405,352 $13.2 Million

Others Institutions Holding ALBO

# of Institutions

Shares Held

865

Call Options Held

Put Options Held

View Full List

About ALBIREO PHARMA, INC.

Ticker ALBO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 19,612,500
Description
Albireo Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other liver or gastrointestinal diseases and disorders. The company offers Bylvay for the treatment of progressive familial intrahepatic cholestasis, as we...

More about ALBO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Arrow Mark Colorado Holdings LLC, based on Form 13F filings with the SEC.

News

Stay updated on Arrow Mark Colorado Holdings LLC with notifications on news.

Account